Saturday, April 2, 2011: 1:00 PM-2:15 PM
Trinity Ballroom (Hilton Anatole)
Abstracts
74
Outcomes of antimicrobial stewardship intervention in Japanese university hospital
Takashi Niwa, PhD, Department of Pharmacy, Gifu University Hospital;
Yasutaka Shinoda, Laboratory of Pharmacy Practice and Social Science, Gifu Pharmaceutical University;
Akio Suzuki, PhD, Department of Pharmacy, Gifu University Hospital;
Tomofumi Ohmori, MS, Department of Pharmacy, Gifu University Hospital;
Mituru Yasuda, MD, PhD, The Center for Nutritional Support & Infection Control, Gifu University Hospital;
Hirotoshi Ohta, PhD, The Center for Nutritional Support & Infection Control, Gifu University Hospital;
Ayumi Fukao, RN, LPN, ICN, Gifu University Hospital;
Tadashi Sugiyama, PhD, Laboratory of Pharmacy Practice and Social Science, Gifu Pharmaceutical University;
Nobuo Murakami, MD, PhD, The Center for Nutritional Support & Infection Control, Gifu University Hospital;
Yoshinori Itoh, PhD, Department of Pharmacy, Gifu University Hospital
75
Impact of cefepime restriction on susceptibility profile of Gram negative bacilli related to healthcare associated infections in a tertiary hospital in Brazil
Priscila R. Oliveira, MD, Hospital das Clinicas;
Adriana P. Paula, RN, Hospital das Clinicas;
Karine Dal-Paz, PharmD, Hospital das Clinicas;
Cassia S. Felix, RN, Hospital das Clinicas;
Flavia Rossi, MD, PhD, Hospital das Clinicas;
Ana Lucia M. Lima, MD, PhD, Hospital das Clinicas
77
Antimicrobial Stewardship at a 100 Bed, Full-Service, Acute Care Hospital
Donald F. Storey, MD, FACP, Dallas ID Associates;
Autumn Nguyen, PharmD, Las Colinas Medical Center;
Fung Chang, PharmD, MBA, Medical Center of McKinney;
Perry Pate, MD, Dallas ID Associates
78
Clinical Outcomes from a Community Antimicrobial Stewardship Program with Limited Resources
Anurag Malani, MD, St Joseph Mercy Health System;
Patrick G. Richards, Pharm.D., St Joseph Mercy Health System;
Shikha Kapila, Pharm.D., St Joseph Mercy Health System;
Michael Otto, MD, St Joseph Mercy Health System;
Jennifer Czerwinski, B.A., St Joseph Mercy Health System;
Bonita Singal, M.D., Ph.D., St Joseph Mercy Health System
79
Effect of Piperacillin/Tazobactam (P/T) De-restriction on Antibiotic Usage and Susceptibility of Pseudomonas aeruginosa Isolates
Jennifer Christoff Pisano, MD, University of Chicago Medical Center;
Ryan Dunn, MD, University of Chicago Medical Center;
Benjamin Brielmaier, PharmD, University of Chicago Medical Center;
Armand M. Ryden, MD, UCLA David Geffen School of Medicine;
Emily Landon Mawdsley, MD, University of Chicago Medical Center;
Stephen G. Weber, MD, MSc, University of Chicago Medical Center
80
Fluoroquinolone Usage in the University of Iowa Hospitals and Clinics (UIHC) and Physicians' Knowledge about the Spectrum of Antimicrobial Agents
Paul Christine, BA, The University of Iowa College of Medicine and College of Public Health;
Porpon Rotjanapan, The University of Iowa College of Medicine;
Birgir Johannsson, MD, Univ of Iowa Hosp & Clinics;
Sarah Johnson, PharmD, Univ of Iowa Hosp & Clinics;
Loreen Herwaldt, MD, The University of Iowa College of Medicine, College of Public Health, and Hospitals and Clinics
82
Trimethoprim/Sulfamethoxazole Compared to Daptomycin or Linezolid for the Treatment of Infections due to Methicillin-Resistant Staphylococcus aureus
Michelle Campbell, BA, Detroit Medical Center, Wayne State University;
Bharath Sunkara, MD, Detroit Medical Center, Wayne State University;
Neelu Chugh, MD, Detroit Medical Center, Wayne State University;
Aparna Poona, PharmB, Detroit Medical Center, Wayne State University;
Melanie N. Wilson, BS, Detroit Medical Center, Wayne State University;
Judy Moshos, MT, Detroit Medical Center, Wayne State University;
Suchitha Bheemreddy, MD, Detroit Medical Center, Wayne State University;
Kimberley Ku, BS, Detroit Medical Center, Wayne State University;
Karambir Singh, MD, Detroit Medical Center, Wayne State University;
Teena Chopra, MD, Detroit Medical Center, Wayne State University;
Kayoko Hayakawa, MD, PhD, Detroit Medical Center, Wayne State University;
Odaliz Abreu-Lanfranco, MD, Detroit Medical Center, Wayne State University;
Paul R. Lephart, PhD, Detroit Medical Center, Wayne State University;
Jason M. Pogue, PharmD, Detroit Medical Center, Wayne State University;
Sorabh Dhar, MD, Detroit Medical Center, Wayne State University;
Keith S. Kaye, MD, MPH, Detroit Medical Center, Wayne State University;
Dror Marchaim, MD, Detroit Medical Center, Wayne State University
83
Fosfomycin activity versus carbapenem-resistant Enterobacteriaceae (CRE) and vancomycin-resistant Enterococcus (VRE) at the Detroit Medical Center (DMC)
Jason M. Pogue, PharmD, Detroit Medical Center, Wayne State University;
Dror Marchaim, MD, Detroit Medical Center, Wayne State University;
Ryan P. Mynatt, PharmD, Detroit Medical Center, Wayne State University;
Jing J. Zhao, PharmD, Detroit Medical Center, Wayne State University;
Odaliz Abreu-Lanfranco, MD, Detroit Medical Center, Wayne State University;
Suchitha Bheemreddy, MD, Detroit Medical Center, Wayne State University;
Bharath Sunkara, MD, Detroit Medical Center, Wayne State University;
Kayoko Hayakawa, MD, PhD, Detroit Medical Center, Wayne State University;
Teena Chopra, MD, Detroit Medical Center, Wayne State University;
Sorabh Dhar, MD, Detroit Medical Center, Wayne State University;
Keith S. Kaye, MD, MPH, Detroit Medical Center, Wayne State University;
Paul R. Lephart, PhD, Detroit Medical Center, Wayne State University
84
Extended-spectrum beta-lactamase (ESBL)-producers and piperacillin/tazobactam in the era of lowered break-points and no confirmatory tests
Jason M. Pogue, PharmD, Detroit Medical Center, Wayne State University;
Dror Marchaim, MD, Detroit Medical Center, Wayne State University;
Paul R. Lephart, PhD, Detroit Medical Center, Wayne State University;
Ryan P. Mynatt, PharmD, Detroit Medical Center, Wayne State University;
Jing J. Zhao, PharmD, Detroit Medical Center, Wayne State University;
Suchitha Bheemreddy, MD, Detroit Medical Center, Wayne State University;
Bharath Sunkara, MD, Detroit Medical Center, Wayne State University;
Judy Moshos, MT, Detroit Medical Center, Wayne State University;
Kayoko Hayakawa, MD, PhD, Detroit Medical Center, Wayne State University;
Teena Chopra, MD, Detroit Medical Center, Wayne State University;
Sorabh Dhar, MD, Detroit Medical Center, Wayne State University;
Keith S. Kaye, MD, MPH, Detroit Medical Center, Wayne State University
85
Successful Piperacillin-tazobactam De-escalation Program as an Antimicrobial Stewardship Initiative
Jean A. Patel, PharmD, Northwestern Memorial Hospital;
Marc H. Scheetz, PharmD, MSc, Northwestern Memorial Hospital;
John S. Esterly, PharmD, Northwestern Memorial Hospital;
Maureen K. Bolon, MD, MS, Northwestern University;
Pavani Reddy, MD, Ontario Agency for Health Protection and Promotion;
Sarah Sutton, MD, Northwestern University;
Michael J. Postelnick, RPh, Northwestern Memorial Hospital
86
Antimicrobial Stewardship Through Mandatory Pre-Discharge Infectious Disease Consultation for Community-based Parenteral Anti-infective Therapy
Nabin K. Shrestha, MD, MPH, Cleveland Clinic;
Archana Bhaskaran, MD, Cleveland Clinic;
Nikole M. Scalera, MD, MS, Cleveland Clinic;
Steven K. Schmitt, MD, Cleveland Clinic;
Susan J. Rehm, MD, Cleveland Clinic;
Steven M. Gordon, MD, Cleveland Clinic
87
Don't “Bench” Long-Term Care Facilities: Benchmarking Antibiotic Use at Four Veterans Affairs Community Living Centers
Danielle M. Olds, RN, PhD, Louis Stokes Cleveland VA Medical Center;
Emily P. Peron, PharmD, University of Pittsburgh;
Amy Hirsch, PharmD, Louis Stokes Cleveland VA Medical Center;
Barbara M. Heath, MSNEd, RN, Louis Stokes Cleveland VA Medical Center;
Curtis J. Donskey, MD, Louis Stokes Cleveland VA Medical Center;
Robert A. Bonomo, MD, Louis Stokes Cleveland VA Medical Center;
Robin Jump, MD, PhD, Louis Stokes Cleveland VA Medical Center
88
Does Piperacillin-Tazobactam Minimum Inhibitory Concentration for Pseudomonas aeruginosa Predict Outcome of Pseudomonal Bacteremia?
Iona Munjal, MD, Montefiore Medical Center;
Vinit Gupta, MD, Montefiore Medical Center;
Philip Chung, PharmD, Montefiore Medical Center;
Yi Guo, PharmD, Montefiore Medical Center;
Michael Levi, ScD, Montefiore Medical Center;
Belinda Ostrowsky, MD, MPH, Montefiore Medical Center
89
Treatment of Outpatient Community-Acquired Pneumonia: Risk Factors for Drug-Resistant Streptococcus pneumoniae and Effect on Antibiotic Selection
Joy Sakai, MD, University of Colorado-Denver;
Timothy C. Jenkins, MD, Denver Health Medical Center;
Claire J. Swartwood, PharmD, Denver Health Medical Center;
Bryan C. Knepper, Denver Health Medical Center;
Jason S. Haukoos, Denver Health Medical Center;
Jeremy A. Long, Denver Health Medical Center;
Connie S. Price, MD, University of Colorado Health Sciences Center; Denver Health Medical Center;
William J. Burman, Denver Health Medical Center
90
Improved Diagnosis and Treatment of Clostridium difficile Infection in a Long-term Care Facility after Initiation of an On-Site Infectious Diseases Consultation Service
Lucy A. Jury, NP, Geriatric Research, Education, and Clinical Center, Louis Stokes Cleveland VA Medical Center;
Robin L.P. Jump, MD, PhD, Geriatric Research, Education, and Clinical Center, Louis Stokes Cleveland VA Medical Center;
Brett M. Sitzlar, BS, Geriatric Research, Education, and Clinical Center, Louis Stokes Cleveland VA Medical Center;
Dubert Guerrero, MD, Louis Stokes Cleveland VA Medical Center;
Sirisha Kundrapu, MD, Geriatric Research, Education, and Clinical Center, Louis Stokes Cleveland VA Medical Center;
Curtis J. Donskey, MD, Geriatric Research, Education, and Clinical Center, Louis Stokes Cleveland VA Medical Center
94
National Clostridium difficile Infection (CDI) related hospitalizations approaches MRSA related hospitalizations-The need for antibiotic stewardship programs
Teena Chopra, MD, Detroit Medical Center, Wayne State University;
Dror Marchaim, MD, Detroit Medical Center, Wayne State University;
George Alangaden, MD, Detroit Medical Center,Wayne State University;
Keith S. Kaye, MD, MPH, Detroit Medical Center, Wayne State University;
Tom Taylor, PhD, Detroit Medical Center, Wayne State University
95
Decreased Antibiotic Utilization after Implementation of a Guideline for Inpatient Cellulitis and Cutaneous Abscess
Timothy C. Jenkins, MD, Denver Health Medical Center;
Bryan C. Knepper, MPH, MSc, Denver Health Medical Center;
Allison L. Sabel, MD, PhD, MPH, Denver Health Medical Center;
Ellen E. Sarcone, MD, Denver Health Medical Center;
Jeremy A. Long, MD, MPH, Denver Health Medical Center;
Jason S. Haukoos, MD, MSc, Denver Health Medical Center;
Steven J. Morgan, MD, Denver Health Medical Center;
Walter L. Biffl, MD, Denver Health Medical Center;
Andrew W. Steele, MD, MPH, MSc, Denver Health Medical Center;
Connie S. Price, MD, Denver Health Medical Center;
Philip S. Mehler, MD, Denver Health Medical Center;
William J. Burman, MD, Denver Health Medical Center
![[ Visit SHEA online ]](images/banner.gif)